Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
XERS (Xeris Biopharma Holdings, Inc.) has 11 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Suppliers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
241 institutional managers report a position in Xeris Biopharma Holdings, Inc. worth $868.4M between them, filed on form 13F for the quarter ending 2026-06-30. 35 of them hold 80% of it, the largest being BlackRock, Inc. at 13.25%.
216 more managers in the register
35 managers hold 80% of the $868.4M institutional base. The other 206 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
Prev close 7.48 · opened flat. High/low 7.50 at 11:30 am ET, 7.42 at 2:00 pm ET.
Xeris Biopharma Holdings, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
via Wellington Management Group LLP, Qube Research & Technologies Ltd, Federated Investors Inc +8 more · 2.16% of XERS, 3.24% of FIVE
via Qube Research & Technologies Ltd, Algert Global LLC, Federated Investors Inc +7 more · 2.64% of XERS, 2.10% of OIS
via Qube Research & Technologies Ltd, Armistice Capital, LLC, Federated Investors Inc +4 more · 2.64% of XERS, 2.86% of ARVN
via Qube Research & Technologies Ltd, Parkman Healthcare Partners LLC, Norges Bank +8 more · 2.64% of XERS, 1.93% of UPB
via Wellington Management Group LLP, Algert Global LLC, Federated Investors Inc +6 more · 2.16% of XERS, 2.46% of JANX
via Wellington Management Group LLP, Qube Research & Technologies Ltd, Norges Bank +9 more · 2.16% of XERS, 1.96% of AVPT
Managers holding a meaningful stake in XERS also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.